Urological Cancer Related to Familial Syndromes

Overview

Journal Int Braz J Urol

Specialty Urology

Date 2016 Nov 8

PMID 27819754

Citations 5

Authors

Walter Henriques da Costa

George Jabboure Netto

Isabela Werneck da Cunha

Affiliations

Soon will be listed here.

Abstract

Cancer related to hereditary syndromes corresponds to approximately 5-10% of all tumors. Among those from the genitourinary system, many tumors had been identified to be related to genetic syndromes in the last years with the advent of new molecular genetic tests. New entities were described or better characterized, especially in kidney cancer such as hereditary leiomyomatosis renal cell carcinoma (HLRCC), succinate dehydrogenase kidney cancer (SDH-RCC), and more recently BAP1 germline mutation related RCC. Among tumors from the bladder or renal pelvis, some studies had reinforced the role of germline mutations in mismatch repair (MMR) genes, especially in young patients. In prostate adenocarcinoma, besides mutations in BRCA1 and BRCA2 genes that are known to increase the incidence of high-risk cancer in young patients, new studies have shown mutation in other gene such as HOXB13 and also polymorphisms in MYC, MSMB, KLK2 and KLK3 that can be related to hereditary prostate cancer. Finally, tumors from testis that showed an increased in 8 - 10-fold in siblings and 4 - 6-fold in sons of germ cell tumors (TGCT) patients, have been related to alteration in X chromosome. Also genome wide association studies GWAS pointed new genes that can also be related to increase of this susceptibility.

Citing Articles

Pathogenic Insights into DNA Mismatch Repair (MMR) Genes-Proteins and Microsatellite Instability: Focus on Adrenocortical Carcinoma and Beyond.

Carsote M, Turturea I, Turturea M, Valea A, Nistor C, Gheorghisan-Galateanu A Diagnostics (Basel). 2023; 13(11).

PMID: 37296718 PMC: 10252762. DOI: 10.3390/diagnostics13111867.

Nephrolithiasis-Associated Renal Cell Carcinoma in Patients Who Underwent Nephrectomy: A Single-Center Experience.

Mirsya Warli S, Mantiri B, Sihombing B, Putra Siregar G, Febrian Prapiska F World J Oncol. 2023; 14(1):94-100.

PMID: 36895998 PMC: 9990740. DOI: 10.14740/wjon1560.

Noninvasive circulating tumor cell and urine cellular (rs2228001, A2815C) and (rs25487, G1196A) polymorphism detection as an effective screening panel for genitourinary system cancers.

Wu C, Xu C, Wang G, Zhang D, Zhao X Transl Cancer Res. 2022; 8(8):2803-2812.

PMID: 35117037 PMC: 8797689. DOI: 10.21037/tcr.2019.10.47.

Prevalence of pathogenic variants in DNA damage response and repair genes in patients undergoing cancer risk assessment and reporting a personal history of early-onset renal cancer.

Hartman T, Demidova E, Lesh R, Hoang L, Richardson M, Forman A Sci Rep. 2020; 10(1):13518.

PMID: 32782288 PMC: 7419503. DOI: 10.1038/s41598-020-70449-5.

The long-term rapid increase in incidence of adenocarcinoma of the kidney in the USA, especially among younger ages.

Zheng T, Zhu C, Bassig B, Liu S, Buka S, Zhang X Int J Epidemiol. 2019; 48(6):1886-1896.

PMID: 31317187 PMC: 7967823. DOI: 10.1093/ije/dyz136.

References

Stanford J, Ostrander E . Familial prostate cancer. Epidemiol Rev. 2001; 23(1):19-23. DOI: 10.1093/oxfordjournals.epirev.a000789. View

Jensen D, Proctor M, Marquis S, Gardner H, Ha S, Chodosh L . BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene. 1998; 16(9):1097-112. DOI: 10.1038/sj.onc.1201861. View

Ricketts C, Shuch B, Vocke C, Metwalli A, Bratslavsky G, Middelton L . Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. J Urol. 2012; 188(6):2063-71. PMC: 3856891. DOI: 10.1016/j.juro.2012.08.030. View

Thompson D, Easton D . Cancer Incidence in BRCA1 mutation carriers. J Natl Cancer Inst. 2002; 94(18):1358-65. DOI: 10.1093/jnci/94.18.1358. View

Lonser R, Glenn G, Walther M, Chew E, Libutti S, Linehan W . von Hippel-Lindau disease. Lancet. 2003; 361(9374):2059-67. DOI: 10.1016/S0140-6736(03)13643-4. View

Chan-Smutko G . Genetic testing by cancer site: urinary tract. Cancer J. 2012; 18(4):343-9. DOI: 10.1097/PPO.0b013e31826246ac. View

Vanharanta S, Buchta M, McWhinney S, Virta S, Peczkowska M, Morrison C . Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. Am J Hum Genet. 2003; 74(1):153-9. PMC: 1181902. DOI: 10.1086/381054. View

Geary J, Sasieni P, Houlston R, Izatt L, Eeles R, Payne S . Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC). Fam Cancer. 2007; 7(2):163-72. DOI: 10.1007/s10689-007-9164-6. View

Eeles R, Goh C, Castro E, Bancroft E, Guy M, Olama A . The genetic epidemiology of prostate cancer and its clinical implications. Nat Rev Urol. 2013; 11(1):18-31. DOI: 10.1038/nrurol.2013.266. View

10.

Walther M, Choyke P, Glenn G, Lyne J, Rayford W, Venzon D . Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery. J Urol. 1999; 161(5):1475-9. DOI: 10.1016/s0022-5347(05)68930-6. View

11.

Harbour J, Onken M, Roberson E, Duan S, Cao L, Worley L . Frequent mutation of BAP1 in metastasizing uveal melanomas. Science. 2010; 330(6009):1410-3. PMC: 3087380. DOI: 10.1126/science.1194472. View

12.

Maddock I, Moran A, Maher E, Teare M, Norman A, Payne S . A genetic register for von Hippel-Lindau disease. J Med Genet. 1996; 33(2):120-7. PMC: 1051837. DOI: 10.1136/jmg.33.2.120. View

13.

Mandriota S, Turner K, Davies D, Murray P, Morgan N, Sowter H . HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron. Cancer Cell. 2002; 1(5):459-68. DOI: 10.1016/s1535-6108(02)00071-5. View

14.

Haas N, Nathanson K . Hereditary kidney cancer syndromes. Adv Chronic Kidney Dis. 2013; 21(1):81-90. PMC: 3872053. DOI: 10.1053/j.ackd.2013.10.001. View

15.

Houldsworth J, Korkola J, Bosl G, Chaganti R . Biology and genetics of adult male germ cell tumors. J Clin Oncol. 2006; 24(35):5512-8. DOI: 10.1200/JCO.2006.08.4285. View

16.

Au K, Williams A, Roach E, Batchelor L, Sparagana S, Delgado M . Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet Med. 2007; 9(2):88-100. DOI: 10.1097/gim.0b013e31803068c7. View

17.

Bausch B, Jilg C, Glasker S, Vortmeyer A, Lutzen N, Anton A . Renal cancer in von Hippel-Lindau disease and related syndromes. Nat Rev Nephrol. 2013; 9(9):529-38. DOI: 10.1038/nrneph.2013.144. View

18.

Ni Y, Zbuk K, Sadler T, Patocs A, Lobo G, Edelman E . Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes. Am J Hum Genet. 2008; 83(2):261-8. PMC: 2495063. DOI: 10.1016/j.ajhg.2008.07.011. View

19.

Lichtenstein P, Holm N, Verkasalo P, Iliadou A, Kaprio J, Koskenvuo M . Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000; 343(2):78-85. DOI: 10.1056/NEJM200007133430201. View

20.

Skeldon S, Semotiuk K, Aronson M, Holter S, Gallinger S, Pollett A . Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer. Eur Urol. 2012; 63(2):379-85. DOI: 10.1016/j.eururo.2012.07.047. View